Godavari Drugs

{
  "main_header": {
    "sid": 765253,
    "name": "Godavari Drugs",
    "stock_name": "Godavari Drugs",
    "full_name": "Godavari Drugs Ltd",
    "name_url": "stocks-analysis/godavari-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "122.75",
    "chg": -0.25,
    "chgp": "-0.2%",
    "dir": -1,
    "prev_price": "123.00",
    "mcapval": "128.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530317,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE362C01012",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "04:19 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "2.07 k",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/godavari-drugs-765253-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Godavari Drugs Gains 0.28%: 2 Key Events Shaping This Week’s Movement",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-gains-028-2-key-events-shaping-this-weeks-movement-4023156",
        "imagepath": "",
        "date": "2026-05-30 15:04:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Stock opens at Rs.126.95, modest gain of 0.16%</p>\n                    <p><strong>26 May:</strong> Strong rally with 1.54% gain despite Sensex decline</p>\n                    <p><strong>27 May:</strong> New 52-week high reached at Rs.135.25</p>\n                    <p><strong>29 May:</strong> Q4 FY26 results released; stock closes lower at Rs.127.10 (-2.23%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.126.75</div>\n                    </div>\n                    <div class=\"stat-item\">\n ..."
      },
      {
        "title": "Are Godavari Drugs Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-godavari-drugs-ltd-latest-results-good-or-bad-4021796",
        "imagepath": "",
        "date": "2026-05-29 19:39:39",
        "description": "Godavari Drugs Ltd has reported its financial results for Q4 FY26, showcasing a significant quarter-on-quarter increase in both net sales and net profit. Specifically, net sales reached ₹33.16 crores, reflecting a growth of 49.50% compared to the previous quarter, which had seen a decline. The net profit for the same quarter was ₹1.29 crores, marking a 69.66% increase from the prior quarter's profit of ₹0.76 crores. This quarter also saw the company achieving its highest-ever quarterly net sales, reversing a trend of three consecutive quarters of volatile performance.\n\nHowever, the operational metrics reveal some challenges. The operating margin, excluding other income, contracted to 8.84%, down from 11.14% in the previous quarter, indicating that the revenue growth may have come at the expense of operational efficiency. Additionally, the return on equity (ROE) stands at 8.82%, which is below industry stand..."
      },
      {
        "title": "Godavari Drugs Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-hold-4019857",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GodavariDrugsLt_mojoScore_4019857.png",
        "date": "2026-05-29 10:11:03",
        "description": "Godavari Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Godavari Drugs Q4 FY26: Strong Quarter Masks Deeper Concerns About Long-Term Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/godavari-drugs-q4-fy26-strong-quarter-masks-deeper-concerns-about-long-term-growth-4020734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GodavariDrugs_quaterlyResult_4020734.png",
        "date": "2026-05-29 09:44:34",
        "description": "Godavari Drugs Ltd., a micro-cap active pharmaceutical ingredients (API) manufacturer, reported a robust performance in Q4 FY26 with net profit surging 69.66% quarter-on-quarter to ₹1.29 crores, whilst revenue jumped an impressive 49.50% to ₹33.16 crores. However, the positive quarterly momentum stands in stark contrast to the company's troubling five-year track record of negative sales growth and deteriorating operational efficiency, raising critical questions about the sustainability of this recent upturn."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 135.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-hits-new-52-week-high-at-rs13525-4016863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GodavariDrugsLt_priceRelatedfactors_4016863.png",
        "date": "2026-05-27 12:35:17",
        "description": "Surging past Rs 135.25 on 27 May 2026, Godavari Drugs Ltd has reached a fresh 52-week high, marking a 31.51% gain over the past year against the Sensex’s decline of 6.83%. This milestone caps a four-day winning streak that has propelled the stock 6.24% higher, underscoring a robust price momentum that stands out in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Godavari Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-hold-by-marketsmojo-3996665",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GodavariDrugsLt_mojoScore_3996665.png",
        "date": "2026-05-18 10:10:43",
        "description": "Godavari Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 134.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-hits-new-52-week-high-at-rs1345-3985109",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GodavariDrugsLt_priceRelatedfactors_3985109.png",
        "date": "2026-05-11 09:45:00",
        "description": "Surging to a fresh 52-week high of Rs 134.5 on 11 May 2026, Godavari Drugs Ltd has demonstrated remarkable price momentum, outperforming the broader market with a 39.21% gain over the past year compared to the Sensex’s decline of 3.94%. This milestone underscores a sustained rally driven predominantly by strong technical signals across multiple timeframes."
      },
      {
        "title": "Godavari Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-hold-by-marketsmojo-3979483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GodavariDrugsLt_mojoScore_3979483.png",
        "date": "2026-05-07 10:11:23",
        "description": "Godavari Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 132.96",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-hits-new-52-week-high-at-rs13296-3968465",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GodavariDrugsLt_priceRelatedfactors_3968465.png",
        "date": "2026-04-29 14:05:12",
        "description": "Surging past its previous peaks, Godavari Drugs Ltd touched a fresh 52-week high of Rs 132.96 on 29 Apr 2026, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of bullish technical indicators and sustained outperformance relative to its sector and the broader market."
      }
    ],
    "total": 183,
    "sid": "765253",
    "stock_news_url": "https://www.marketsmojo.com/news/godavari-drugs-765253"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-May-2026",
      "details": "Please find the enclosed newspaper publication for your information",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarter Ended March 31 2026",
      "datetime": "27-May-2026",
      "details": "Refer Enclosed",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Wednesday 27Th Day Of May2026",
      "datetime": "27-May-2026",
      "details": "We are enclosing Audited Financial Results for the Quarter ended 31st march 2026 which are approved in Board Meeting which was held today i.e Wednesday 27th Day of May 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Godavari Drugs Gains 0.28%: 2 Key Events Shaping This Week’s Movement

2026-05-30 15:04:55

Key Events This Week

25 May: Stock opens at Rs.126.95, modest gain of 0.16%

26 May: Strong rally with 1.54% gain despite Sensex decline

27 May: New 52-week high reached at Rs.135.25

29 May: Q4 FY26 results released; stock closes lower at Rs.127.10 (-2.23%)

Week Open

Rs.126.75

...

Read full news article

Are Godavari Drugs Ltd latest results good or bad?

2026-05-29 19:39:39

Godavari Drugs Ltd has reported its financial results for Q4 FY26, showcasing a significant quarter-on-quarter increase in both net sales and net profit. Specifically, net sales reached ₹33.16 crores, reflecting a growth of 49.50% compared to the previous quarter, which had seen a decline. The net profit for the same quarter was ₹1.29 crores, marking a 69.66% increase from the prior quarter's profit of ₹0.76 crores. This quarter also saw the company achieving its highest-ever quarterly net sales, reversing a trend of three consecutive quarters of volatile performance. However, the operational metrics reveal some challenges. The operating margin, excluding other income, contracted to 8.84%, down from 11.14% in the previous quarter, indicating that the revenue growth may have come at the expense of operational efficiency. Additionally, the return on equity (ROE) stands at 8.82%, which is below industry stand...

Read full news article

Godavari Drugs Ltd is Rated Hold

2026-05-29 10:11:03

Godavari Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Godavari Drugs Q4 FY26: Strong Quarter Masks Deeper Concerns About Long-Term Growth

2026-05-29 09:44:34

Godavari Drugs Ltd., a micro-cap active pharmaceutical ingredients (API) manufacturer, reported a robust performance in Q4 FY26 with net profit surging 69.66% quarter-on-quarter to ₹1.29 crores, whilst revenue jumped an impressive 49.50% to ₹33.16 crores. However, the positive quarterly momentum stands in stark contrast to the company's troubling five-year track record of negative sales growth and deteriorating operational efficiency, raising critical questions about the sustainability of this recent upturn.

Read full news article

Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 135.25

2026-05-27 12:35:17

Surging past Rs 135.25 on 27 May 2026, Godavari Drugs Ltd has reached a fresh 52-week high, marking a 31.51% gain over the past year against the Sensex’s decline of 6.83%. This milestone caps a four-day winning streak that has propelled the stock 6.24% higher, underscoring a robust price momentum that stands out in the Pharmaceuticals & Biotechnology sector.

Read full news article

Godavari Drugs Ltd is Rated Hold by MarketsMOJO

2026-05-18 10:10:43

Godavari Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 134.5

2026-05-11 09:45:00

Surging to a fresh 52-week high of Rs 134.5 on 11 May 2026, Godavari Drugs Ltd has demonstrated remarkable price momentum, outperforming the broader market with a 39.21% gain over the past year compared to the Sensex’s decline of 3.94%. This milestone underscores a sustained rally driven predominantly by strong technical signals across multiple timeframes.

Read full news article

Godavari Drugs Ltd is Rated Hold by MarketsMOJO

2026-05-07 10:11:23

Godavari Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Broad-Based Technical Strength Lifts Godavari Drugs Ltd to 52-Week High of Rs 132.96

2026-04-29 14:05:12

Surging past its previous peaks, Godavari Drugs Ltd touched a fresh 52-week high of Rs 132.96 on 29 Apr 2026, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of bullish technical indicators and sustained outperformance relative to its sector and the broader market.

Read full news article

View All News